RE:RE:RE:RE:A/O Sept. 08th ONCY's cash runway is until late Q4, 2024 Is it possible that AA has been applied for? good question.
Possibly since ONCY previoulsy treated approximately 128 pancreatic cancer patients.
Current law allows for a drug to be approved under this pathway if it treats a serious condition and fills an unmet medical need on a surrogate or intermediate clinical endpoint. Simply put, rather than having to show that patients live longer if they use a cancer drug, a company can show that from treatment, a patient has met another, surrogate endpoint—such as that their tumors have shrunk in size. The FDA also allows intermediate clinical endpoints, which show short-term benefit in chronic diseases or a benefit to a clinical endpoint that predicts an overall clinical effect.